BIOEMTECH is a preclinical CRO that aims to bridge the gap between ex vivo studies and in vivo molecular imaging, by providing cost effective solutions in terms of instrumentation and services. BIOEMTECH has developed and commercialized the "eyes", the first desktop cameras, suitable for whole body, real time imaging of PET and SPECT isotopes in mice. In addition, BIOEMTECH undertakes full studies for evaluating new compounds in our authorized laboratories that include animal facility, in vitro lab, radiochemistry lab and in vivo imaging with microPET/SPECT/CT and optical imaging. Our clients include both Universities and Pharma companies. The company is GLP accredited for pwrforming Toxicological studies and is licensed to use radioisotopes, hence capable of evaluating diagnostic and therapeutic radiopharmaceuticals. Finally, BIOEMTECH is rather active as an imaging partner in several projects including H2020, FET, ERA, ITN and more. 

Biotechnology

Clinical Trials

Life Sciences

BIOEMTECH

BIOEMTECH's headquarters in Gerakas, Greece

This department focuses on shaping and guiding the strategic direction of the organization.

Corporate Strategy

This department focuses on advancing research and development in biological sciences and biotechnology applications.

Biotechnology Research

This department focuses on identifying growth opportunities and forming strategic partnerships to drive revenue.

Business Development

This department focuses on the design, development, and maintenance of software applications and systems.

Engineering Department

This department oversees the operations, regulations, and standards of laboratory facilities to ensure optimal functioning and compliance.

Laboratory Management

This department focuses on delivering application solutions and executing marketing strategies to enhance product visibility and user engagement.

People (2)

Jobs (0)

Other teams

Biotechnology Research

Business Development

Engineering Department

Laboratory Management

Applications and Marketing